ZAPPULO, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 890
EU - Europa 590
AS - Asia 105
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.610
Nazione #
US - Stati Uniti d'America 856
IT - Italia 241
NL - Olanda 113
DE - Germania 108
CN - Cina 60
UA - Ucraina 33
CA - Canada 32
IE - Irlanda 26
SG - Singapore 25
FI - Finlandia 22
CI - Costa d'Avorio 18
CH - Svizzera 17
GB - Regno Unito 13
FR - Francia 9
IN - India 7
VN - Vietnam 7
EG - Egitto 4
HK - Hong Kong 2
MK - Macedonia 2
MX - Messico 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
CL - Cile 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
PL - Polonia 1
SI - Slovenia 1
Totale 1.610
Città #
Chandler 179
Amsterdam 109
Ashburn 106
Naples 69
Millbury 57
Des Moines 37
Krefeld 32
Napoli 31
Ottawa 28
Lawrence 25
Princeton 23
Boston 19
Nanjing 18
Basel 17
Singapore 15
Wilmington 14
Beijing 11
Seattle 10
Milan 8
Washington 7
Hebei 6
Nanchang 6
Pune 6
Tianjin 6
Bologna 4
Council Bluffs 4
Dong Ket 4
Los Angeles 4
Pomigliano D'arco 4
Qualiano 4
Brescia 3
Chicago 3
Dung 3
Kronberg 3
Montalbano Jonico 3
Rome 3
Shenyang 3
Acquaviva Delle Fonti 2
Cairo 2
Changsha 2
Dublin 2
Fairfield 2
Formia 2
Gualtieri 2
Hanover 2
Hong Kong 2
Jinan 2
Lanzhou 2
Lappeenranta 2
New York 2
Norwalk 2
Paris 2
Pozzuoli 2
Redwood City 2
Richland 2
Richmond 2
Serra 2
Skopje 2
Sorrento 2
Vittorio Veneto 2
Alcamo 1
Andover 1
Astana 1
Aversa 1
Bari 1
Bayreuth 1
Boardman 1
Brussels 1
Caivano 1
Casalnuovo Di Napoli 1
Caserta 1
Casoria 1
Castellammare di Stabia 1
Catania 1
Cava De' Tirreni 1
Città Di Castello 1
Cologno Monzese 1
Columbus 1
Dubai 1
Duncan 1
Edinburgh 1
Ercolano 1
Foggia 1
Fremont 1
Galveston 1
Helsinki 1
Houston 1
Indiana 1
Jiaxing 1
La Canada Flintridge 1
Ljubljana 1
London 1
Marano di Napoli 1
Marigliano 1
Melbourne 1
Messina 1
Mexico City 1
Monteforte Irpino 1
Monterrey 1
Montreal 1
Totale 970
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 130
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 56
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 56
Infezione da cytomegalovirus 51
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 50
Asunaprevir for hepatitis C: A safety evaluation 46
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 43
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 40
Il Virus varicella Zoster 38
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 38
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 37
Beclabuvir for the treatment of hepatitis C 35
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 34
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 34
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 33
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 33
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 33
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 33
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 33
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 32
DNA detection of herpetic viruses in dried blood spots in children with autism spectrum disorders 30
Epstein-Barr virus 29
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 29
Decreased warfarin effects in elder with recurrent Clostridium difficile infection during fidaxomicin therapy: a case report 28
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 28
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 28
Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders 27
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 27
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 27
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 25
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 25
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 24
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 22
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 22
Prevalence of human herpesvirus-6 and epstein barr virus infections in children with autistic spectrum disorders 21
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 21
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 20
HSV 20
Response to measles-mumps-rubella vaccine in children with autistic spectrum disorders 20
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 20
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 20
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 20
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 20
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 19
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 18
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 18
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 18
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 17
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 17
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 17
Diabetes and COVID-19: The potential role of mTOR 16
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 16
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 16
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 16
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 15
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 13
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 13
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 13
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 13
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development 13
No evidence of congenital varicella zoster virus infection assessed through dried blood spot in children with autism spectrum disorders 11
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 10
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 10
The role of curcumin in liver diseases 7
Totale 1.744
Categoria #
all - tutte 7.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 3 9
2019/2020107 41 5 1 4 10 3 3 2 2 4 21 11
2020/2021115 20 4 6 9 17 7 8 3 16 17 1 7
2021/2022290 5 3 3 2 1 12 1 10 27 30 77 119
2022/2023654 51 31 20 35 55 62 23 157 71 118 26 5
2023/2024366 16 69 77 33 24 74 3 35 7 7 21 0
Totale 1.744